AWA
ABMD

Arkadios Wealth Advisors’s Abiomed Inc ABMD Stock Holding History

Arkadios Wealth Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-130
Closed -$42K – 1910
2021
Q3 		$42K Hold
130
– – 0.01% 944
2021
Q2 		$40K Sell
130
-1
-0.8% -$307 ﹤0.01% 1007
2021
Q1 		$41K Hold
131
– – 0.01% 748
2020
Q4 		$42K Buy
131
+10
+8% +$2.77K 0.01% 588
2020
Q3 		$34.7K Buy
+121
New +$34.9K 0.02% 480

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Arkadios Wealth Advisors's ABMD Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 130 shares — an estimated $42K sold.

Arkadios Wealth Advisors first reported a position in ABMD in Q3 2020 and held it in 5 quarters. The position peaked at $42K in Q3 2021. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 130 Abiomed Inc shares in Q4 2021, an estimated $42K.
  • Arkadios Wealth Advisors first reported a position in Abiomed Inc in Q3 2020 and held it in 5 quarters.
  • Arkadios Wealth Advisors's Abiomed Inc position peaked at $42K in Q3 2021.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.